Monday 5th July 2021 |
Text too small? |
Cannasouth Limited is pleased to announce it has today entered into two conditional agreements to acquire the balance of the stakes that it does not already own in its cultivation and manufacturing joint venture businesses.
1. Acquisition of outstanding interest in Cannasouth Cultivation Limited
Cannasouth has entered into a conditional agreement with Aaron Craig and his family interests (Craig Family Interests) to acquire the remaining 50% stake in Joint Venture business Cannasouth Cultivation Limited that Cannasouth does not already own, for an aggregate purchase price of $3,540,000.
2. Acquisition of outstanding interest in Midwest Pharmaceutics NZ Limited
Cannasouth has entered into a conditional agreement with Mark Balchin and Greenmeadows Health Limited (“Midwest Vendors”) to acquire the remaining 40 per cent shareholding in Hawkes Bay-based Midwest Pharmaceutics NZ Limited (Midwest) that it does not already own, together with the shareholder loans made by the Midwest Vendors to Midwest for an aggregate purchase price of $1,026,000. CEO of Midwest, Mark Balchin, will continue as Chief Manufacturing Officer for the Group.
Cannasouth Proposes to undertake a Capital Raising to Fund the Acquisitions. The Company is currently finalising its capital raising strategy and will release details to the market in due course.
Please see the link below for details
NZX MAP_CBD_Cannasouth to Consolidate Operations FINAL
No comments yet
PaySauce Quarterly Market Update - September 2024
October 2nd Morning Report
Rua Releases Annual Report for Year Ended 30 June 2024
SCL - Settlement of orchard sales
The Warehouse Group 2024 ASM and Director Nominations
AIR - Update on Chief Operational Integrity and Safety Officer
Comvita Limited - Annual Report 2024
September 27th Morning Report
Spark announces departure of Finance Director
FBU - Retail Entitlement Offer Opens